HutchMED (China) LIMITED APIC, Share-based Payment Arrangement, Increase for Cost Recognition
HutchMED (China) LIMITED (HMDCF) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $14.27 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Shareholders' Equity › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-03-05
- HutchMED (China) LIMITED apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2019-12-31 was $2.25M, a 26.77% decline year-over-year.
- HutchMED (China) LIMITED apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2019-09-30 was $1.75M, a 35.27% decline year-over-year.
- HutchMED (China) LIMITED apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2019-06-30 was $2.15M, a 27.03% decline year-over-year.
- HutchMED (China) LIMITED apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2019-03-31 was $3.28M, a 35.44% increase year-over-year.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2025-12-31 | $14.27M 20-F · filed 2026-03-05 | |||
| 2025-06-30 | $9.36M 6-K · filed 2025-08-07 | |||
| 2024-12-31 | $30.32M 20-F · filed 2026-03-05 | |||
| 2024-06-30 | $20.89M 6-K · filed 2025-08-07 | |||
| 2023-12-31 | $29.80M 20-F · filed 2026-03-05 | |||
| 2023-06-30 | $17.05M 6-K · filed 2024-07-31 | |||
| 2022-12-31 | $39.72M 20-F · filed 2025-03-19 | |||
| 2022-06-30 | $27.43M 6-K · filed 2023-07-31 | |||
| 2021-12-31 | $36.24M 20-F · filed 2024-02-28 | |||
| 2021-06-30 | $21.06M 6-K · filed 2022-08-01 | |||
| 2020-12-31 | $15.96M 20-F · filed 2023-02-28 | |||
| 2020-06-30 | $8.22M 6-K · filed 2021-07-28 | |||
| 2019-12-31 | $2.25M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | $3.99M derived: sum of 2 quarters · filed 2022-03-03 | $6.14M derived: sum of 3 quarters · filed 2022-03-03 | $9.42M 20-F · filed 2022-03-03 |
| 2019-09-30 | $1.75M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $3.90M derived: sum of 2 quarters · filed 2020-07-30 | $7.18M 6-K · filed 2020-01-21 | $10.24M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $2.15M derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | $5.43M 6-K · filed 2020-07-30 | $8.50M derived: sum of 3 quarters · filed 2021-03-04 | $11.20M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $3.28M 6-K · filed 2019-06-06 | $6.35M derived: sum of 2 quarters · filed 2021-03-04 | $9.04M derived: sum of 3 quarters · filed 2021-03-04 | $11.99M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | $3.07M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | $5.76M derived: sum of 2 quarters · filed 2021-03-04 | $8.71M derived: sum of 3 quarters · filed 2021-03-04 | $11.14M 20-F · filed 2021-03-04 |
| 2018-09-30 | $2.70M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $5.65M derived: sum of 2 quarters · filed 2020-01-21 | $8.07M 6-K · filed 2020-01-21 | |
| 2018-06-30 | $2.95M derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | $5.37M 6-K · filed 2019-07-30 | ||
| 2018-03-31 | $2.42M 6-K · filed 2019-06-06 | |||
| 2017-12-31 | $2.80M 20-F · filed 2020-03-03 | |||
| 2017-06-30 | $1.68M 6-K · filed 2018-07-27 | |||
| 2016-12-31 | $2.76M 20-F · filed 2019-03-11 | |||
| 2016-06-30 | $1.77M 6-K · filed 2017-07-31 | |||
| 2015-12-31 | $401.00K 20-F · filed 2018-03-12 |